The DOI matches its Crossref record.
Staging of Alzheimer-Related Cortical Destruction
Abstract
The gradual intraneuronal accumulation of an insoluble fibrous material which partly consists of abnormally phosphorylated tau protein (neurofibrillary change) represents an important neuropathological hallmark of Alzheimer’s disease. Neurofibrillary tangles and neuropil threads formed from this material develop in only a few types of cortical pyramidal cells. The first changes are seen in the entorhinal cortex. The destructive process then spreads into the hippocampal formation and eventually encroaches upon the isocortex. This sequence of events permits the distinction of six stages with a progressive increase in the severity of cortical destruction. The entorhinal region serves as an important interface between the isocortex and hippocampus. This interface function is markedly impaired due to the early deterioration of the entorhinal cortex. Severe entorhinal involvement is considered to represent the morphological counterpart of clinically incipient Alzheimer’s disease. Similar changes are found in mentally impaired individuals suffering from Parkinson’s disease or progressive supranuclear palsy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“On the basis of the review of an enormous sample of cross-sectional autopsy data, the pattern of NFT development across the clinical spectrum of disease has been integrated in Braak neuropathologic staging (60, 298, 299).”
From Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature (2012) · cites this paper as [299]
Citations
Cited by
Sorted by citations
Items 601–700 of 838
Lim, S., Tran, D. N., Kieu, Z., Chen, C., Villanueva, E., Ghiaar, S., Gallup, V., Zumkehr, J., Cribbs, D. H., Rodríguez‐Ortiz, C. J., et al. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-01894-6 · Cited by 8
Gao, N., Liu, Z., Deng, Y., Chen, H., Ye, C., Yang, Q., & Ma, T. (2023) · Human Brain Mapping · doi:10.1002/hbm.26460 · Cited by 7
Adams, S. L., Benayoun, L., Tilton, K., Mellott, T. J., Seshadri, S. S., Blusztajn, J. K., & Delalle, I. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-171065 · Cited by 9
Porchet, R., Probst, A., Dráberová, E., Dráber, P., Riederer, I. M., & Riederer, B. M. (2003) · Neuroreport · doi:10.1097/01.wnr.0000072844.93264.31 · Cited by 9
Zhu, C., Li, H., Song, Z., Jiang, M., Song, L., Lin, L., Wang, X., & Zheng, Q. (2024) · Health Information Science and Systems · doi:10.1007/s13755-023-00269-0 · Cited by 6
“The hippocampus is often considered to be one of the earliest brain regions affected in AD patients [46–48], and various neuro-imaging studies have demonstrated the structural and functional connectivity abnormalities of the hippocampus in patients with AD and MCI [49–52].”
Hippocampal functional connectivity in Alzheimer’s disease: a resting state 7T fMRI study
Velayudhan, L., Francis, S., Dury, R. J., et al. (2020) · International Psychogeriatrics · doi:10.1017/s1041610220003440 · Cited by 7
“The hippocampus is one of the earliest affected brain regions in AD (Braak et al., 1993), with its degradation being a hallmark of AD inmany structural and functional imaging studies.”
BackgroundEffects of Acupuncture on Neuropathic Pain: Mechanisms in Animal Models
Jang, J., & Park, H. (2022) · Perspectives on Integrative Medicine · doi:10.56986/pim.2022.09.004 · Cited by 7
“controls memory and has been studied in humans in association with various cognitive dysfunctions, such as dementia, Alzheimer’s disease [24,26], and in mice to study neuropathic pain [27].”
BackgroundSato, K., Yamanaka, Y., Ishii, M., Ishibashi, K., Ogura, Y., Ohtani‐Kaneko, R., Nishihara, M., & Nedachi, T. (2014) · Bioscience Biotechnology and Biochemistry · doi:10.1080/09168451.2014.936343 · Cited by 7
Chatterjee, P., & Roy, D. (2016) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2016.1214085 · Cited by 7
Animal Models of Alzheimer’s Disease
Amram, S., & Frenkel, D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803690-7.00003-x · Cited by 8
The Aged Dog as a Natural Model of Alzheimer’s Disease Progression
Araujo, J. A., Baulk, J., & de Rivera, C. (2017) · Springer eBooks · doi:10.1007/978-3-319-53219-6_4 · Cited by 9
Han, A. R., Yang, J. W., Na, J.-M., Choi, S. Y., & Cho, S. W. (2019) · BMB Reports · doi:10.5483/bmbrep.2019.52.7.231 · Cited by 7
The tuberomamillary nucleus in neuropsychiatric disorders
Shan, L., Fronczek, R., Lammers, G. J., & Swaab, D. F. (2021) · Handbook of clinical neurology · doi:10.1016/b978-0-12-820107-7.00024-0 · Cited by 7
Turski, G. N., & Ikonomidou, C. (2014) · Springer eBooks · doi:10.1007/978-1-4614-5836-4_84 · Cited by 7
Repetition priming in mild cognitive impairment and mild dementia: Impact of educational attainment
O’Shea, D. M., Wit, L. D., Yutsis, M. V., Castro, M., & Smith, G. E. (2017) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803395.2017.1347253 · Cited by 6
Ceyhan, E., Ceritoglu, C., Beg, M. F., Wang, L., Morris, J. C., Csernansky, J. G., Miller, M. I., & Ratnanather, J. T. (2008) · arXiv (Cornell University) · doi:10.48550/arxiv.0806.1473 · Cited by 7
“Numerous post-mortem studies have shown that neurofibrillary tangles and amyloid plaques characteristic of Alzheimer’s Disease (AD) are prominent within the hippocampus of individuals with mild dementia of the Alzheimer’s type (DAT) and that the distribution of these neuropathological markers becomes more widespread t…”
BackgroundAkkoyun, M., Koçoğlu, K., Boz, H. E., et al. (2024) · Brain and Behavior · doi:10.1002/brb3.3567 · Cited by 6
Circulating adipokines and MRI markers of brain aging in middle-aged adults from the community
Satizábal, C. L., Himali, J. J., Conner, S. C., Beiser, A., Maillard, P., Vasan, R. S., DeCarli, C. S., & Seshadri, S. S. (2024) · Journal of Alzheimer s Disease · doi:10.1177/13872877241289043 · Cited by 6
“Previous work suggests that the anterior hippocampus is affected earlier in the progression to Alzheimer ’ s disease, 58,59 and our observations may point to metabolically driven early hippocampal neurodegenerative processes in midlife.”
Du, X., Zhang, M., Wang, R., Zeng, Z., Zhao, W., Fang, B., Lan, H., Hung, W., & Gao, H. (2024) · Nutrients · doi:10.3390/nu16213586 · Cited by 7
Kordi, R., Andrews, T. J., & Hicar, M. D. (2025) · Virology · doi:10.1016/j.virol.2025.110523 · Cited by 6
Structural Magnetic Resonance Imaging-Derived Biomarkers for Alzheimer's Disease
Barnes, J., Foster, J., & Fox, N. C. (2007) · Biomarkers in Medicine · doi:10.2217/17520363.1.1.79 · Cited by 6
“Plaque pathology usually begins in the neocortex [11,12].”
BackgroundLelos, M. J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818084-6.00002-7 · Cited by 5
Jin, Z., Sethi, S. K., Li, B., Tang, R., Li, Y., Hsu, C. C.-T., He, N., Haacke, E. M., & Yan, F. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.572595 · Cited by 5
“Early AD has a predilection to involve the limbic system including the entorhinal cortex, hippocampus and the mammillary bodies before spreading to other brain regions (Braak et al., 1993; Xu et al., 2000; Baloyannis et al., 2016).”
BackgroundBagattini, C., Esposito, M., Ferrari, C., Mazza, V., & Brignani, D. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.930877 · Cited by 6
“Several indications support the fact that AD neurodegeneration may affect hemispheres in an asymmetric fashion (Haxby and Rapoport, 1985; Braak et al., 1993; Derflinger et al., 2011; Finke et al., 2013).”
BackgroundBeyer, N., Coulson, D. T. R., Quinn, J. G., Brockbank, S., Hellemans, J., Irvine, G. B., Ravid, R., & Johnston, J. A. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.05.020 · Cited by 6
Leite, R. E. P., & Grinberg, L. T. (2015) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201400192 · Cited by 6
Magnetic resonance signal processing tool for diagnostic classification
Suleimanov, Y., Radchenko, S. P., Lefterov, O., Нетреба, А. В., Vasnyov, S., Sava, V., Sanchez‐Ramos, J., Prockop, L. D., & Duara, R. (2016) · IEEE International Conference on Electronics and Nanotechnology (ELNANO) · doi:10.1109/elnano.2016.7493042 · Cited by 6
Finger Agnosia in Alzheimer Disease
Shenal, B. V., Jackson, M. D., Crucian, G. P., et al. (2006) · Cognitive and Behavioral Neurology · doi:10.1097/01.wnn.0000213921.02891.1b · Cited by 6
“Studies of stroke patients suggest that injury to the left inferior parietal lobe often induces the 4 elements (finger agnosia, acalculia, agraphia, and right-left confusion) of the Gerstmann syndrome(11) and patients with AD often show pathologic changes in their inferior parietal lobe.(4) It was unclear from lesion…”
BackgroundVascular-Related and Mediated Alterations in Alzheimer’s Disease
Sparks, D. L. (1999) · Cerebral cortex · doi:10.1007/978-1-4615-4885-0_20 · Cited by 6
Metabolic Magnetic Resonance Imaging: A Case for Bioscales in Medicine
Thulborn, K. R., Atkinson, I. C., & Lu, A. (2011) · Springer eBooks · doi:10.1007/978-1-4419-0345-7_44 · Cited by 6
Armstrong, R. A., & Cairns, N. J. (2011) · PubMed · doi:10.14670/hh-26.185 · Cited by 6
“Braak stage of the cases was based on the density and distribution of neurofibrillary tangles (NFT) (Braak et al., 1993).”
BackgroundScarfo, S., Marsella, A. M. A., Grigoriadou, L., Moshfeghi, Y., & McGeown, W. J. (2024) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2024.109006 · Cited by 6
“Therefore, while both the entorhinal cortex (Braak et al., 1993) and misidentification phenomena are associated with a more severe clinical picture, their association appears to be found irrespective of this, suggesting an interesting route to further investigate in the future.”
BackgroundSymposium: What Does the Microbiome Tell Us about Prevention and Treatment of AD/ADRD?
Capocchi, J. K., Figueroa‐Romero, C., Dunham, S. J. B., Faraci, G., Rothman, J. A., Whiteson, K., Seo, D.-O., Holtzman, D. M., Grabrucker, S., Nolan, Y. M., et al. (2024) · Journal of Neuroscience · doi:10.1523/jneurosci.1295-24.2024 · Cited by 6
Longhena, A., Guillemaud, M., Fallani, F. D. V., Migliaccio, R., & Chávez, M. (2025) · Physical review. E · doi:10.1103/physreve.111.044402 · Cited by 5
“According to the anatomopathological model proposed by Braak and Braak [17], the pathology typically spreads from the medial temporal areas, particularly from the entorhinal cortex, to the hippocampal formation.”
Turski, G. N., & Ikonomidou, C. (2022) · Springer eBooks · doi:10.1007/978-3-031-15080-7_84 · Cited by 5
Perri, R., Monaco, M., Fadda, L., Caltagirone, C., & Carlesimo, G. A. (2019) · Journal of Neurology · doi:10.1007/s00415-019-09411-z · Cited by 5
Maladie d’alzheimer, hippocampe et neuroimagerie
Mevel, K., Chételat, G., Desgranges, B., & Eustache, F. (2006) · L Encéphale · doi:10.1016/s0013-7006(06)76306-0 · Cited by 4
Farlow, M. R. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-6231-8.10054-6 · Cited by 5
Neuroimaging of Alzheimer’s Disease, Mild Cognitive Impairment, and Other Dementias
Risacher, S. L., & Saykin, A. J. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6373-4_19 · Cited by 5
Lilja, A. M., Röjdner, J., Mustafiz, T., Thomé, C. M., Storelli, E., Gonzalez, D., Lithner, C. U., Greig, N. H., Nordberg, A. K., & Marutle, A. (2013) · PLoS ONE · doi:10.1371/annotation/79c850e6-4494-4533-b68d-ef4eb72cd65a · Cited by 5
Blood-based biomarkers of Alzheimer’s disease and olfactory decline over 15 years in older adults
Ekström, I., Vetrano, D. L., Valletta, M., Ruane, R., Larsson, M., Fredolini, C., Winblad, B. G., Grande, G., & Laukka, E. J. (2025) · GeroScience · doi:10.1007/s11357-025-02038-1 · Cited by 4
“The interaction between p-tau181 and APOE ε4 corresponds well to regional patterns of AD pathology, as amyloid and tau pathologies originate in entorhinal and anter-omedial temporal regions [55, 56], areas essential for olfactory processing [4].”
Huang, S., Nunez, J., Toresco, D. L., Wen, C., Slotabec, L. A., Wang, H., Zhang, H., Rouhi, N., Adenawoola, M. I., & Li, J. (2025) · The FASEB Journal · doi:10.1096/fj.202402725rr · Cited by 4
Weidling, I. W., Preiss, C. N., Chancellor, S. E., Srivastava, G. P., Gibilisco, L., Lin, G., Brennan, M. S., Lee, J. Y., Roth, L. M., Morozova, O., et al. (2025) · Acta Neuropathologica Communications · doi:10.1186/s40478-025-02000-4 · Cited by 5
“Braak staging of AD brain tissue demonstrates selective vulnerability at a regional level, revealing a stereotypical progression of hyperphosphorylated, aggregated Tau inclusions from the locus coeruleus to the entorhinal cortex and, ultimately, throughout the cortex [6, 7, 83].”
Menšíková, K., Matěj, R., Parobková, E., Smětáková, M., & Kaňovský, P. (2021) · Prion · doi:10.1080/19336896.2021.1946378 · Cited by 4
“This process that starts in the entorhinal cortex and spreads over the limbic system and finally extends into neocortical regions has been characterized in detail and formalized in a staging system by Braak and Braak [13,14].”
MethodNeuroimaging Approaches for Elderly Studies
Styliadis, C., Kartsidis, P. E., & Paraskevopoulos, E. (2015) · Advances in psychology, mental health, and behavioral studies (APMHBS) book series · doi:10.4018/978-1-4666-8234-4.ch004 · Cited by 4
Gavett, B. E., Fletcher, E. M., Widaman, K. F., Farias, S. T., DeCarli, C. S., & Mungas, D. (2021) · Neuropsychology · doi:10.1037/neu0000761 · Cited by 4
Intermittent fasting to slow down Alzheimer’s disease
Nicolas, S., & Nolan, Y. M. (2022) · Nature Aging · doi:10.1038/s43587-022-00320-x · Cited by 4
Edwards, L., Thomas, K. R., Weigand, A. J., Edmonds, E. C., Clark, A. L., Brenner, E. K., Banks, S. J., Gilbert, P. E., Nation, D. A., Delano‐Wood, L., et al. (2024) · Cerebral Circulation - Cognition and Behavior · doi:10.1016/j.cccb.2024.100206 · Cited by 4
Abbate, C. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00308 · Cited by 4
Kakhlon, O., Breuer, B., Münnich, A., & Cabantchik, Z. I. (2010) · Humana Press eBooks · doi:10.1007/978-1-60327-514-9_11 · Cited by 4
Posimo, J. M., Titler, A. M., Choi, H. J. H., Unnithan, A. S., & Leak, R. K. (2013) · PLoS ONE · doi:10.1371/annotation/6e168e79-a961-4746-80f7-5626502197af · Cited by 5
Yu, D., Wang, L., Kong, D., & Hongtu Zhu, B. (2020) · arXiv (Cornell University) · Cited by 3
Pait, M. C., Kaye, S. D., Su, Y., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.03.10.532133 · Cited by 4
“Our approach also allows us to explore EVs from a specific brain region vulnerable to AD pathology during amyloid plaque formation (85).”
BackgroundRichard, J. E., Mohammad, A., Go, K. A., McGovern, A. J., Rechlin, R. K., Splinter, T. F. L., Lieblich, S. E., Radovic, L. K., Feng, L., Blankers, S. A., et al. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.106088 · Cited by 4
Basereh, M., Abikenari, M. A., Sadeghzadeh, S., Dunn, T., Freichel, R., Siddarth, P., Ghahremani, D., Lavretsky, H., & Buch, V. P. (2025) · Diagnostics · doi:10.3390/diagnostics15232997 · Cited by 4
“Studies of restorative entrepreneurship demonstrate that sustained, value-aligned engagement with marginalized groups can mitigate exclusion, improve access to care, and enable community-driven solutions, even in resource-constrained or high-stigma environments [4].”
Zhan, L., Tan, G., Dong, J., Deng, Z., Zou, Y., Dan, Z., Wang, R., Luo, Z., & Zhu, X. (2025) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/08919887251336464 · Cited by 3
“34,35 According to the Braak stages, neuro-fi brillary tangels fi rst occurin the entorhinal cortex and hippocampus (transentorhinal stages I and II), then spreading into amygdala and basolateral temporal lobe (limbic stage III – IV), which may correspond to SCD and MCI stage, respectively.”
Latina, V., Introna, M. D., Caligiuri, C., Loviglio, A., Florio, R., Regina, F. L., Pignataro, A., Ammassari‐Teule, M., Calissano, P., & Amadoro, G. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15020509 · Cited by 3
Do Health Science Concepts Influence Care?: The Case for a New Landscape of Aging
Cohen, G. D. (1998) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-199800640-00001 · Cited by 3
Functional MRI Studies of Memory in Aging, Mild Cognitive Impairment, and Alzheimer’s Disease
Risacher, S. L., Wishart, H. A., & Saykin, A. J. (2011) · Springer eBooks · doi:10.1007/978-1-4419-0345-7_24 · Cited by 3
Wan, H. I., Hurko, O., Day, M., & Rutkowski, J. L. (2009) · Drug Development Research · doi:10.1002/ddr.20292 · Cited by 3
“It can be distinguished from rarer forms of dementia by a characteristic pattern of neurodegeneration, most marked in the hippocampus and entorhinal cortex [Braak and Braak, 1991; Braak et al., 1993].”
Armstrong, R. A., & Cairns, N. J. (2011) · Neurological Sciences · doi:10.1007/s10072-011-0639-8 · Cited by 3
“duration of disease, Braak stage [35], brain weight, and disease subtype was tested using Pearson’s correlation coefficient (r).”
Ceyhan, E., Beg, M. F., Ceritoglu, C., Wang, L., Morris, J. C., Csernansky, J. G., Miller, M. I., & Ratnanather, J. T. (2012) · Current Alzheimer Research · doi:10.2174/156720512803251138 · Cited by 3
“Alzheimer’s disease (AD) at its early stages is characterized by the accumulation of neurofibrillary tangles and amyloid plaques within the hippocampus [1–5].”
BackgroundA comparison of the spatial patterns of β-amyloid (Aβ) deposits in five neurodegenerative disorders
Armstrong, R. A. (2018) · Folia Neuropathologica · doi:10.5114/fn.2018.80860 · Cited by 3
On the role of tau phosphorylation in the formation of PHF
Davies, P., & Vincent, I. J. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00039-h · Cited by 3
Aging-Related Memory Disorders—Alzheimer’s Disease
Sweatt, J. D. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374951-2.00012-3 · Cited by 4
Aging-Related Memory Disorders
Sweatt, J. D. (2003) · Elsevier eBooks · doi:10.1016/b978-012678957-7/50013-x · Cited by 3
Ribeiro, R., dos Santos, A. C. S., Calazans, M., de Oliveira, A. C. P., & Vieira, L. B. (2021) · Nutritional Neuroscience · doi:10.1080/1028415x.2021.1972514 · Cited by 4
Reaching a Diagnosis of a Dementia Subtype
Chui, H. C., Lee, A., Cummings, J. L., Tierney, M. C., Payami, H., Guzmán, J. D., Maríamillán, J., Muñoz, D. G., Bermejo, F., Bosscher, L., et al. (2003) · Wiley eBooks · doi:10.1002/9780470752340.ch16 · Cited by 3
Anterolateral entorhinal-hippocampal imbalance in older adults disrupts object pattern separationPreprint
Reagh, Z. M., Noche, J. A., Tustison, N. J., Delisle, D., Murray, E. A., & Yassa, M. A. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/162925 · Cited by 3
“Averaged across similarity levels, lure discrimination was generally poorer in older participants (F(1,38) = 8.”
BackgroundMethodInfluentialGrabrucker, S., Marizzoni, M., Silajdžić, E., Lopizzo, N., Mombelli, E., Nicolas, S., Dohm-Hansen, S., Scassellati, C., Moretti, D. V., Rosa, M., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.11.04.515189 · Cited by 3
Jaramillo, C. J., Nedderman, D. M., Ahat, E., McElwee, J. L., Soper, M. D., Ballard, D. W., Zhang, L., Credille, K. M., Heady, G., Hsi, E. D., et al. (2025) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlaf108 · Cited by 2
Ye, Q., Gast, G., Holmes, T. C., & Xu, X. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.107139 · Cited by 2
Toma de decisiones en pacientes con demencia avanzada
Gac, E. H. (2012) · Revista Médica Clínica Las Condes · doi:10.1016/s0716-8640(12)70278-x · Cited by 2
A Perspective: Challenges in Dementia Research
Stecker, M. M. (2022) · Medicina · doi:10.3390/medicina58101368 · Cited by 3
“What are the characteristics of the nervous system that are different (see Challenge 2) at the onset [113] of pathological aging? 4.”
BackgroundEpigenetic regulons in Alzheimer's disease
Raval, M., Mishra, S., & Tiwari, A. K. (2023) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2023.01.012 · Cited by 2
Detection of Alzheimer’s Disease Using Hybrid Meta-ROI of MRI Structural Images
Zheng, X., & Initiative, O. B. O. T. A. D. N. (2024) · Diagnostics · doi:10.3390/diagnostics14192203 · Cited by 2
“For AD diagnosis using cortical thickness only, the highest AUC = 0.907 is achieved by including the entorhinal, middle temporal, inferior temporal, and fusiform cortices, which agrees with the findings of Jack Jr et al. [2].”
ResultInfluentialNemati, R., Sohrabi-Ashlaghi, A., Saberian, P., Sadeghi, M., Mardani, S., Abadi, A., Yaghoobpoor, A., Heydari, A., Khoshroo, N., Rahnama, Y., et al. (2025) · BMC Neurology · doi:10.1186/s12883-025-04140-5 · Cited by 6
Glotfelty, E. J., Karlsson, T. E., Tovar‐y‐Romo, L. B., Olson, L., Harvey, B. K., & Greig, N. H. (2025) · Current Neuropharmacology · doi:10.2174/011570159x359944250722061312 · Cited by 2
“Braak stages V and VI are the most severe stages of the disease, with broad exposure and damage evident within the neocortex [71].”
Uncovering the Path to Neurodegeneration from Playingfield to Battlefield
Baas, F., & Ramagli, V. (2014) · InTech eBooks · doi:10.5772/57186 · Cited by 1
“By contrast, NFTs in AD are preferentially distributed in the hippocampus and in large projection neurons in layers III and V of the cortex [39].”
BackgroundRing, J. R. (2006) · UKnowledge (University of Kentucky) · Cited by 2
Yokota, T., Akatsu, H., Miyauchi, T., & Heese, K. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.10.050 · Cited by 2
Armstrong, R. A. (2014) · International Journal of Neuroscience · doi:10.3109/00207454.2014.890620 · Cited by 2
“Staging of disease was based on the Braak tangle score [24,25].”
MethodDegenerative Brain Disease and Aging
Essig, M., & van Buchem, M. A. (2012) · Springer eBooks · doi:10.1007/978-88-470-2628-5_10 · Cited by 2
Passive Immunotherapy for Tau Pathology
Davies, P. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802173-6.00014-9 · Cited by 2
Functional MRI Studies of Memory in Aging, Mild Cognitive Impairment, and Alzheimer’s Disease
Zhu, J. K., Risacher, S. L., Wishart, H. A., & Saykin, A. J. (2023) · Springer eBooks · doi:10.1007/978-3-031-10909-6_30 · Cited by 2
Nuclear Tau as an Early Molecular Marker of Alzheimer’s Disease
Bruno, F., Sturiale, V., Brancato, D., Gil, L., Olazabal, I. M., Pinedo, F., Poves, A. B. R., Saccone, S., & Federico, C. (2023) · International Electronic Conference on Biomedicines (IECBM) · doi:10.3390/ecb2023-14131 · Cited by 2
Functional Imaging in Healthy Aging and Alzheimer's Disease
Anderson, N. D., & Grady, C. L. (2004) · KARGER eBooks · doi:10.1159/000079996 · Cited by 2
Weber, D. J., & McFadden, P. N. (1995) · Journal of Protein Chemistry · doi:10.1007/bf01886785 · Cited by 2
Brain Atrophy in Mild Cognitive Impairment: MRI volumetric and voxel-based method study
Pennanen, C. (2006) · Cited by 2
Hubs of long-distance co-alteration in brain pathologyPreprint
Cauda, F., Mancuso, L., Nani, A., Manuello, J., Liloia, D., Gelmini, G., Ficco, L. A., Premi, E., Duca, S., & Costa, T. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/846642 · Cited by 2
“5), long-distance co-alterations of GM increases and GM decreases are found especially in the left hippocampal formation, which is consistent with the assumption that the hippocampus may be the pathological epicentre, as well as with the observation that the left hemisphere is more affected than the right one (Braak e…”
BackgroundResultAlzheimer’s Disease: Neurostructures
Brickman, A. M., & Buchsbaum, M. S. (2008) · Elsevier eBooks · doi:10.1016/b978-012370509-9.00099-1 · Cited by 2
Baron, J. (2022) · Stroke · doi:10.1161/strokeaha.122.041406 · Cited by 2
Liu, Z., Shi, D., Cai, Y. Q., Li, A., Lan, G., Sun, P., Liu, L., Zhu, Y., Yang, J., Zhou, Y., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-3503581/v1 · Cited by 2
Kaski, D. N., & FURMAN, J. M. R. (2025) · doi:10.1093/med/9780198834380.003.0030 · Cited by 1
Liu, F., Cui, J., Li, X., Zhang, Z., Liang, S., Sun, Y., Li, J., Qu, H., Ye, J., Guo, Q., et al. (2025) · Aging Cell · doi:10.1111/acel.70115 · Cited by 2
Filip, P., McCarten, J. R., Hemmy, L. S., Crocker, J., Wolf, M., Thotland, J., Caycı, Z., Kes, T., Michaeli, S., Terpstra, M., et al. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70241 · Cited by 1
“…across preselected regions of interest (ROIs) relevant for general cognitive performance and/or AD pathology as envisioned in Braak's stages (Braak et al. 1993), in relation to the following: – Aim 1: spatial distribution of APP messenger ribonucleic acid (mRNA) expression (Gryglewski et…”
Caravaglios, G., Muscoso, E. G., Blandino, V., et al. (2025) · Clinical EEG and Neuroscience · doi:10.1177/15500594251385006 · Cited by 1
Loss of AT8 Nuclear Tau as a Marker of Neuronal Ageing and Alzheimer’s Disease Progression
Bruno, F., Gil, L., Sturiale, V., Guerrero, C., Poves, A. B. R., Brancato, D., Morales, J., Saccone, S., & Federico, C. (2025) · Biomedicines · doi:10.3390/biomedicines13112587 · Cited by 2
“The amount and type of neurofibrillary tangles observable in the hippocampus are key indicators of disease progression [17,43].”
Glaubitz, E., Wang, X. H., Xi, K., Feiz, F., Pahlajani, S. S., Maloney, T., Tanzi, E. B., Hojjati, H., Zhou, L., Glodzik, L., et al. (2025) · Behavioural Brain Research · doi:10.1016/j.bbr.2025.115889 · Cited by 2
Lavrova, A., Satoh, R., Tosakulwong, N., Weigand, S. D., Jack, C. R., Petersen, R. C., Nguyen, A. T., Reichard, R. R., Prudencio, M., Petrucelli, L., et al. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261421241 · Cited by 1
Metadata
- Authors
- Braak, H., Braak, E., & Bohl, J.
- Affiliations
- Goethe University Frankfurt (DE)
- ORCID
- Braak, Heiko
- Venue
- European Neurology
- Publisher
- S. Karger AG
- Published
- 2008-02-12
- Volume
- 33
- Issue
- 6
- Pages
- 403-408
- ISSN
- 0014-3022 (ISSN-L)
- 1421-9913
- OpenAlex
- W2095422335
- Cited by
- 836
- References
- 0
- Citations by year
- 2026: 15 · 2025: 27 · 2024: 29 · 2023: 34 · 2022: 38 · 2021: 32 · 2020: 35 · 2019: 33 · 2018: 30 · 2017: 40 · 2016: 35 · 2015: 47 · 2014: 36 · 2013: 39 · 2012: 35
- FWCI
- 29.38
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Neurology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, cortical destruction, neurofibrillary tangles, tau protein, neuropil threads, entorhinal cortex, hippocampal formation, neocortex, disease staging, cortical pyramidal neurons, Parkinson's disease, progressive supranuclear palsy, neuropathology
- MeSH terms
- Aged, Alzheimer Disease, Brain Mapping, Cerebral Cortex, Dementia, Diagnosis, Differential, Hippocampus, Humans, Limbic System, Parkinson Disease, Supranuclear Palsy, Progressive, Neurites, Neurofibrillary Tangles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review